[Kliment]

Clinical trials are expensive so unless you're massively well funded (like Moderna and BioNTech are at the moment, and basically nobody else in that space) you have to prioritize for whichever is the most promising based on prelim data. This is a problem trivially solved with money, but for some reason all the promising biotech developers are massively underfunded compared to branches such as killing people or selling advertising.